Back to search
Acute Agitation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Agitation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Agitation trials you may qualify forThis study will explore the effect of ECT treatments plus usual care (ECT+UC) in reducing severe agitation in patients with moderate to severe dementia includin…
Summary. Behavioral and psychological symptoms of dementia (BPSD) represents a huge emotional stress and an important burden for the patients and the caregivers…
The purpose of the study is to improve the pharmacological treatment of psychiatric patients with acute agitation.
This open-label study will utilize treatment with BXCL501 in order to assess the suitability of patient-and lay informant-assessed outcome measures for evaluati…
Haloperidol is known to be a safe alternative medication to control difficult pain, and has been shown effective when compared to placebo for controlling headac…
Agitation is characterized by excessive motor or verbal activity, irritability, uncooperativeness, threatening gestures, and, in some cases, aggressive or viole…